Skip to main content
NCBI home page
Gut logoLink to Gut
. 2001 Oct;49(4):512–518. doi: 10.1136/gut.49.4.512

Human gastric B cell responses can be induced by intestinal immunisation

M Quiding-Jarbrink 1, H Lonroth 1, I Ahlstedt 1, J Holmgren 1, A Svennerholm 1
PMCID: PMC1728478  PMID: 11559648

Abstract

BACKGROUND—In a previous study, we found that oral vaccination induces strong B cell responses in the stomach of Helicobacter pylori infected but not of uninfected individuals. In this study, we have evaluated the possibility of inducing gastric immune responses in H pylori infected volunteers by intestinal and gastric immunisation.
METHODS—H pylori infected subjects were given two doses of an inactivated cholera vaccine, either intestinally via an endoscope approximately 30 cm distal to the pylorus sphincter or intragastrically as small droplets applied directly onto the stomach mucosa. Uninfected individuals received the vaccine by standard oral procedure. Vaccine specific antibody secreting cells in antral and duodenal biopsies were detected by the enzyme linked immunospot assay technique before and seven days after the second immunisation.
RESULTS—Intestinal immunisations resulted in induction of vaccine specific gastric IgA secreting cells in five of eight volunteers. This immunisation schedule also gave rise to specific duodenal antibody secreting cells in seven of eight individuals. Local gastric immunisation resulted in the induction of specific B cells in the gastric mucosa of four of eight volunteers. Gastric antigen application also resulted in B cell responses in the duodenum in all volunteers. Uninfected volunteers receiving the vaccine perorally responded in the duodenum but not in the stomach.
CONCLUSIONS—H pylori infection increases the ability of the gastric mucosa to serve as an expression site for intestinally induced B cell responses. These findings are of importance when designing a therapeutic H pylori vaccine, and based on our results such a vaccine can be delivered along the whole upper gastrointestinal tract.


Keywords: Helicobacter pylori; vaccine; stomach; B cell; lymphocyte trafficking

Full Text

The Full Text of this article is available as a PDF (164.4 KB).

Figure 1  .

Figure 1  

Open in a new tab

Duodenal antibody secreting cell (ASC) responses after intestinal, intragastric, or peroral immunisations. Duodenal biopsies were collected one week before and one week after a second immunisation with cholera vaccine, and IgA secreting ASC reacting with cholera toxin B subunit (CTB) were detected by ELISPOT assays. Data are presented as individual frequencies of CTB specific IgA secreting cells per 104 total IgA secreting cells before (Pre) and after (Post) the respective immunisation regimens. Horizontal lines represent arithmetic mean. Numbers indicate the frequencies of responders in the respective groups.

Figure 2  .

Figure 2  

Open in a new tab

Gastric antibody secreting cell (ASC) responses after intestinal or intragastric immunisations. Gastric biopsies were collected one week before and one week after a second immunisation with cholera vaccine, and ASC reacting with cholera toxin B subunit (CTB) were detected by ELISPOT assays. Data are presented as individual frequencies of CTB specific IgA secreting cells per 104 total IgA secreting cells before (Pre) and after (Post) the respective immunisation regimens. Horizontal lines represent arithmetic mean. One individual had very high levels of CTB reactive ASC at the first examination but only background levels after immunisation. However, as this subject had equally high levels of BSA reactive ASC before immunisation, the ASC observed in the preimmunisation specimen most likely represented non-specific reactions and hence data from this individual were not incorporated. Numbers indicate the frequencies of responders in the respective groups.

Figure 3  .

Figure 3  

Open in a new tab

Circulating antibody secreting cell (ASC) responses after intestinal, intragastric, or peroral immunisation. Venous blood was collected before and after immunisation via the indicated routes and was analysed for the presence of cholera toxin B subunit (CTB) specific ASC in ELISPOT assays. Data are presented as individual frequencies of CTB specific IgG and IgA secreting cells before and after the respective immunisation regimens. Horizontal lines represent arithmetic mean. Numbers indicate the frequencies of responders in the respective groups. Vaccine specific ASC could not be detected before immunisation in any of the volunteers.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergquist C., Johansson E. L., Lagergård T., Holmgren J., Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun. 1997 Jul;65(7):2676–2684. doi: 10.1128/iai.65.7.2676-2684.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blanchard T. G., Czinn S. J., Maurer R., Thomas W. D., Soman G., Nedrud J. G. Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice. Infect Immun. 1995 Apr;63(4):1394–1399. doi: 10.1128/iai.63.4.1394-1399.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boehm U., Klamp T., Groot M., Howard J. C. Cellular responses to interferon-gamma. Annu Rev Immunol. 1997;15:749–795. doi: 10.1146/annurev.immunol.15.1.749. [DOI] [PubMed] [Google Scholar]
  4. Corthésy-Theulaz I., Porta N., Glauser M., Saraga E., Vaney A. C., Haas R., Kraehenbuhl J. P., Blum A. L., Michetti P. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology. 1995 Jul;109(1):115–121. doi: 10.1016/0016-5085(95)90275-9. [DOI] [PubMed] [Google Scholar]
  5. Crabtree J. E., Shallcross T. M., Heatley R. V., Wyatt J. I. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut. 1991 Dec;32(12):1473–1477. doi: 10.1136/gut.32.12.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Czerkinsky C., Moldoveanu Z., Mestecky J., Nilsson L. A., Ouchterlony O. A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J Immunol Methods. 1988 Nov 25;115(1):31–37. doi: 10.1016/0022-1759(88)90306-7. [DOI] [PubMed] [Google Scholar]
  7. Czinn S. J., Cai A., Nedrud J. G. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine. 1993;11(6):637–642. doi: 10.1016/0264-410x(93)90309-l. [DOI] [PubMed] [Google Scholar]
  8. D'Elios M. M., Manghetti M., De Carli M., Costa F., Baldari C. T., Burroni D., Telford J. L., Romagnani S., Del Prete G. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol. 1997 Jan 15;158(2):962–967. [PubMed] [Google Scholar]
  9. Dixon M. F., Genta R. M., Yardley J. H., Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996 Oct;20(10):1161–1181. doi: 10.1097/00000478-199610000-00001. [DOI] [PubMed] [Google Scholar]
  10. Dogan A., Du M., Koulis A., Briskin M. J., Isaacson P. G. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol. 1997 Nov;151(5):1361–1369. [PMC free article] [PubMed] [Google Scholar]
  11. Doidge C., Crust I., Lee A., Buck F., Hazell S., Manne U. Therapeutic immunisation against Helicobacter infection. Lancet. 1994 Apr 9;343(8902):914–915. doi: 10.1016/s0140-6736(94)90032-9. [DOI] [PubMed] [Google Scholar]
  12. Elizalde J. I., Gómez J., Panés J., Lozano M., Casadevall M., Ramírez J., Pizcueta P., Marco F., Rojas F. D., Granger D. N. Platelet activation In mice and human Helicobacter pylori infection. J Clin Invest. 1997 Sep 1;100(5):996–1005. doi: 10.1172/JCI119650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Eriksson K., Quiding-Järbrink M., Osek J., Nordström I., Hjulström M., Holmgren J., Czerkinsky C. Anatomic segmentation of the intestinal immune response in nonhuman primates: differential distribution of B cells after oral and rectal immunizations to sites defined by their source of vascularization. Infect Immun. 1999 Nov;67(11):6210–6212. doi: 10.1128/iai.67.11.6210-6212.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ermak T. H., Giannasca P. J., Nichols R., Myers G. A., Nedrud J., Weltzin R., Lee C. K., Kleanthous H., Monath T. P. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med. 1998 Dec 21;188(12):2277–2288. doi: 10.1084/jem.188.12.2277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ferrero R. L., Thiberge J. M., Kansau I., Wuscher N., Huerre M., Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6499–6503. doi: 10.1073/pnas.92.14.6499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ferrero R. L., Thiberge J. M., Labigne A. Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice. Gastroenterology. 1997 Jul;113(1):185–194. doi: 10.1016/s0016-5085(97)70094-5. [DOI] [PubMed] [Google Scholar]
  17. Genta R. M., Hamner H. W., Graham D. Y. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol. 1993 Jun;24(6):577–583. doi: 10.1016/0046-8177(93)90235-9. [DOI] [PubMed] [Google Scholar]
  18. Ghiara P., Rossi M., Marchetti M., Di Tommaso A., Vindigni C., Ciampolini F., Covacci A., Telford J. L., De Magistris M. T., Pizza M. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun. 1997 Dec;65(12):4996–5002. doi: 10.1128/iai.65.12.4996-5002.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hamlet A. K., Erlandsson K. I., Olbe L., Svennerholm A. M., Backman V. E., Pettersson A. B. A simple, rapid, and highly reliable capsule-based 14C urea breath test for diagnosis of Helicobacter pylori infection. Scand J Gastroenterol. 1995 Nov;30(11):1058–1063. doi: 10.3109/00365529509101607. [DOI] [PubMed] [Google Scholar]
  20. Hamlet A., Lindholm C., Nilsson O., Olbe L. Aspirin-induced gastritis, like Helicobacter pylori-induced gastritis disinhibits acid secretion in humans: relation to cytokine expression. Scand J Gastroenterol. 1998 Apr;33(4):346–356. doi: 10.1080/00365529850170964. [DOI] [PubMed] [Google Scholar]
  21. Haneberg B., Kendall D., Amerongen H. M., Apter F. M., Kraehenbuhl J. P., Neutra M. R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun. 1994 Jan;62(1):15–23. doi: 10.1128/iai.62.1.15-23.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hatz R. A., Rieder G., Stolte M., Bayerdörffer E., Meimarakis G., Schildberg F. W., Enders G. Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology. 1997 Jun;112(6):1908–1919. doi: 10.1053/gast.1997.v112.pm9178683. [DOI] [PubMed] [Google Scholar]
  23. Holmgren J., Svennerholm A. M., Jertborn M., Clemens J., Sack D. A., Salenstedt R., Wigzell H. An oral B subunit: whole cell vaccine against cholera. Vaccine. 1992;10(13):911–914. doi: 10.1016/0264-410x(92)90324-d. [DOI] [PubMed] [Google Scholar]
  24. Hopkins S., Kraehenbuhl J. P., Schödel F., Potts A., Peterson D., de Grandi P., Nardelli-Haefliger D. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun. 1995 Sep;63(9):3279–3286. doi: 10.1128/iai.63.9.3279-3286.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jertborn M., Svennerholm A. M., Holmgren J. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine. Vaccine. 1996 Oct;14(15):1459–1465. doi: 10.1016/s0264-410x(96)00071-0. [DOI] [PubMed] [Google Scholar]
  26. Jertborn M., Svennerholm A. M., Holmgren J. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine. 1992;10(2):130–132. doi: 10.1016/0264-410x(92)90030-n. [DOI] [PubMed] [Google Scholar]
  27. Karttunen R., Karttunen T., Ekre H. P., MacDonald T. T. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut. 1995 Mar;36(3):341–345. doi: 10.1136/gut.36.3.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kleanthous H., Myers G. A., Georgakopoulos K. M., Tibbitts T. J., Ingrassia J. W., Gray H. L., Ding R., Zhang Z. Z., Lei W., Nichols R. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun. 1998 Jun;66(6):2879–2886. doi: 10.1128/iai.66.6.2879-2886.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lee C. K., Weltzin R., Thomas W. D., Jr, Kleanthous H., Ermak T. H., Soman G., Hill J. E., Ackerman S. K., Monath T. P. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis. 1995 Jul;172(1):161–172. doi: 10.1093/infdis/172.1.161. [DOI] [PubMed] [Google Scholar]
  30. Lindholm C., Quiding-Järbrink M., Lönroth H., Hamlet A., Svennerholm A. M. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun. 1998 Dec;66(12):5964–5971. doi: 10.1128/iai.66.12.5964-5971.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Luzza F., Imeneo M., Maletta M., Monteleone G., Doldo P., Biancone L., Pallone F. Isotypic analysis of specific antibody response in serum, saliva, gastric and rectal homogenates of Helicobacter pylori-infected patients. FEMS Immunol Med Microbiol. 1995 Feb;10(3-4):285–288. doi: 10.1111/j.1574-695X.1995.tb00045.x. [DOI] [PubMed] [Google Scholar]
  32. Marchetti M., Aricò B., Burroni D., Figura N., Rappuoli R., Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 1995 Mar 17;267(5204):1655–1658. doi: 10.1126/science.7886456. [DOI] [PubMed] [Google Scholar]
  33. Mattsson A., Lönroth H., Quiding-Järbrink M., Svennerholm A. M. Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination. J Clin Invest. 1998 Jul 1;102(1):51–56. doi: 10.1172/JCI22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mattsson A., Quiding-Järbrink M., Lönroth H., Hamlet A., Ahlstedt I., Svennerholm A. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect Immun. 1998 Jun;66(6):2705–2712. doi: 10.1128/iai.66.6.2705-2712.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mattsson A., Tinnert A., Hamlet A., Lönroth H., Bölin I., Svennerholm A. M. Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Clin Diagn Lab Immunol. 1998 May;5(3):288–293. doi: 10.1128/cdli.5.3.288-293.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. McGhee J. R., Mestecky J., Dertzbaugh M. T., Eldridge J. H., Hirasawa M., Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 1992;10(2):75–88. doi: 10.1016/0264-410x(92)90021-b. [DOI] [PubMed] [Google Scholar]
  37. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol. 1987 Jul;7(4):265–276. doi: 10.1007/BF00915547. [DOI] [PubMed] [Google Scholar]
  38. Michetti M., Kelly C. P., Kraehenbuhl J. P., Bouzourene H., Michetti P. Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against helicobacter infection in mice. Gastroenterology. 2000 Jul;119(1):109–118. doi: 10.1053/gast.2000.8548. [DOI] [PubMed] [Google Scholar]
  39. Michetti P., Corthésy-Theulaz I., Davin C., Haas R., Vaney A. C., Heitz M., Bille J., Kraehenbuhl J. P., Saraga E., Blum A. L. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology. 1994 Oct;107(4):1002–1011. doi: 10.1016/0016-5085(94)90224-0. [DOI] [PubMed] [Google Scholar]
  40. Moss S. F., Legon S., Davies J., Calam J. Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut. 1994 Nov;35(11):1567–1570. doi: 10.1136/gut.35.11.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nadal D., Albini B., Schläpfer E., Chen C., Brodsky L., Ogra P. L. Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils. Clin Exp Immunol. 1991 Sep;85(3):358–364. doi: 10.1111/j.1365-2249.1991.tb05732.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Pappo J., Thomas W. D., Jr, Kabok Z., Taylor N. S., Murphy J. C., Fox J. G. Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis. Infect Immun. 1995 Apr;63(4):1246–1252. doi: 10.1128/iai.63.4.1246-1252.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Parsonnet J., Hansen S., Rodriguez L., Gelb A. B., Warnke R. A., Jellum E., Orentreich N., Vogelman J. H., Friedman G. D. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994 May 5;330(18):1267–1271. doi: 10.1056/NEJM199405053301803. [DOI] [PubMed] [Google Scholar]
  44. Peek R. M., Jr, Blaser M. J. Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am J Med. 1997 Feb;102(2):200–207. doi: 10.1016/s0002-9343(96)00273-2. [DOI] [PubMed] [Google Scholar]
  45. Quiding-Järbrink M., Granström G., Nordström I., Holmgren J., Czerkinsky C. Induction of compartmentalized B-cell responses in human tonsils. Infect Immun. 1995 Mar;63(3):853–857. doi: 10.1128/iai.63.3.853-857.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Quiding M., Nordström I., Kilander A., Andersson G., Hanson L. A., Holmgren J., Czerkinsky C. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest. 1991 Jul;88(1):143–148. doi: 10.1172/JCI115270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Shimoyama T., Everett S. M., Dixon M. F., Axon A. T., Crabtree J. E. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol. 1998 Oct;51(10):765–770. doi: 10.1136/jcp.51.10.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994 Jan 28;76(2):301–314. doi: 10.1016/0092-8674(94)90337-9. [DOI] [PubMed] [Google Scholar]
  49. Svennerholm A. M., Holmgren J., Black R., Levine M., Merson M. Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J Infect Dis. 1983 Mar;147(3):514–522. doi: 10.1093/infdis/147.3.514. [DOI] [PubMed] [Google Scholar]
  50. Thomas J. E., Austin S., Dale A., McClean P., Harding M., Coward W. A., Weaver L. T. Protection by human milk IgA against Helicobacter pylori infection in infancy. Lancet. 1993 Jul 10;342(8863):121–121. doi: 10.1016/0140-6736(93)91327-i. [DOI] [PubMed] [Google Scholar]
  51. Veenendaal R. A., Götz J. M., Schroijen V., Kurban F., Bernards A. T., Veselic M., Peña A. S., Lamers C. B. Diagnosis of Helicobacter pylori infection by specific gastric mucosal IgA and IgG pylori antibodies. J Clin Pathol. 1995 Nov;48(11):990–993. doi: 10.1136/jcp.48.11.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wyatt J. I., Rathbone B. J. Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol Suppl. 1988;142:44–49. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES